CutisPharma, Inc. — Form D

CutisPharma, Inc. of WILMINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-30. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2014-12-30
• Form: D
• Accession: 0001628863-14-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $20.0M
• Amount sold: $20.0M
• Investors: 2
• Date of first sale: 2014-12-16
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-231093

Issuer

• Name: CutisPharma, Inc.
• CIK: 0001628863
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 841 WOBURN STREET, WILMINGTON, MA, 01887
• Phone: 781-935-8141

Officers, directors & promoters (8)

More

• CIK 1628863 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search